The fast part and the slow part
Antidepressants alter neurotransmitter availability — primarily serotonin, and for some classes noradrenaline — within hours of the first dose. This is the fast part and is why side effects appear quickly: nausea, headache, sleep changes, restlessness. The slow part is receptor-level adaptation in brain regions involved in mood, motivation, and threat response. Maudsley Prescribing Guidelines and major psychiatric reviews describe this adaptation as taking weeks rather than hours, which is why the medication can feel like it is doing nothing in the first two to three weeks even when it is working exactly as expected.
What the major guidelines say about timing
NICE NG222, RANZCP Clinical Practice Guidelines, and the Royal College of Psychiatrists describe the timeline in similar terms:
Side effects present and often peaking. Mood typically unchanged. This is the hardest part of the window — symptoms from the medication without the benefit yet.
Side effects often begin to ease. Mood usually still unchanged. Some people notice subtle early signals — slightly better sleep, a little less reactivity — but this is not yet the response.
First measurable mood change typically appears for those who will respond. NICE recommends a minimum trial of four to six weeks before assessing response.
Clinical review recommended if there has been no meaningful change at all. NICE and RANZCP both suggest considering dose adjustment, switching, or augmentation at this point.
Continued steady improvement for many patients, even after the initial response. The benefit often keeps building well past the first sign of effect.
What Cochrane reviews show
Cochrane Library reviews of antidepressant efficacy report meaningful clinical effect sizes accumulating by weeks six to eight at an adequate dose, with continued improvement for many patients to twelve weeks and beyond. Stopping the medication in weeks one to three — when side effects are present and benefits are not yet measurable — is too early to assess effect and is consistently identified as a high-risk practice in adherence research.
Why some people take longer
Individual variation in response time is real and documented across the clinical literature. Factors discussed in Maudsley Prescribing Guidelines and major psychiatric reviews include the specific medication and dose, the underlying condition, sleep, alcohol use, concurrent medications, and pharmacogenetic differences in how the body metabolises the drug. A slower response is not a personal failing — it is documented across patient populations and well within the expected range.
What the evidence suggests can help in the waiting weeks
Keep a short daily note — sleep, body, mood. Patient self-tracking is endorsed across NICE, RANZCP, and Royal College of Psychiatrists patient resources.
Take the dose at the same time every day. TGA and FDA product information consistently recommend consistent daily dosing for the SSRI and SNRI classes.
Tell someone you trust. Social support during the waiting period is associated with better adherence in observational research.
Notice subtle changes. Less crying, less reactivity, slightly better sleep — the early signs are quiet and easy to miss without a reference point.
Do not compare your timeline to internet timelines. Individual variation is real and well-documented. Someone else's week two is not your week two.
Frequently asked questions
What is the average time for an antidepressant to start working?
Across NICE, RANZCP, and Royal College of Psychiatrists guidance, the typical window for first meaningful response is four to six weeks at an adequate dose, with response sometimes appearing earlier and sometimes taking up to twelve weeks or longer.
Can an antidepressant start working in the first week?
Early response in the first week or two is documented for a subset of patients but is not the typical pattern. Most clinical descriptions place the first measurable response between weeks four and six. Early changes in sleep or energy can sometimes precede mood improvement.
What if my antidepressant has not started working by week eight?
NICE NG222 and RANZCP both recommend clinical review at this point to consider dose adjustment, switching to a different antidepressant, or augmentation. Lack of response by week eight is the standard decision point in major guidelines — not a reason to give up on treatment.
Related reading
Evidence and sources referenced
- NICE Guideline NG222 — Depression in adults: treatment and management.
- RANZCP — Clinical Practice Guidelines for Mood Disorders.
- Royal College of Psychiatrists — patient information on antidepressants.
- Cochrane Library — antidepressant efficacy reviews.
- Maudsley Prescribing Guidelines in Psychiatry — response timelines and pharmacology.
- NPS MedicineWise — patient resources on antidepressant response (Australia).
- TGA and FDA product information — dosing and onset information for SSRI and SNRI classes.
Track the slow shift, week by week
Causiq is being built to help you know whether your antidepressant is actually working across the first 90 days.
Join the waitlist